Mary Washington Hospital

Fredericksburg, Virginia 22401

1 studies enrolling now · 18 studies all time

What they study most

ADH Inappropriate, ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Anemia, Atherosclerotic Cardiovascular Disease (ASCVD), Bleeding Disorder, Breast Cancer, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Cardiac Surgery, Cardio-pulmonary Bypass

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) — Running, not enrolling
• Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) — Running, not enrolling
• Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy — Running, not enrolling
• Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer — Running, not enrolling
• Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer — Completed
• Management of Antiplatelet Regimen During Surgical Procedures — Completed
• Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) — Running, not enrolling
• Optisure Lead Post Approval Study — Stopped early
• Randomized On-X Anticoagulation Trial — Completed
• Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery — Running, not enrolling
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• Predictive Assay for Decision Making in Adjuvant Therapy — Stopped early
• XIENCE 28 USA Study — Completed
• SOFI: A Quality Improvement Project to Standardize Use of Intravenous Fluids in Hospitalized Pediatric Patients — Completed
• A Registry Study of Breast Microseed Treatment — Status unconfirmed
• Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass — Completed
• Safety and Efficacy Study Comparing Thrombin for Arterial Sealing — Completed